Cannabinoids as novel anti-inflammatory drugs
P Nagarkatti, R Pandey, SA Rieder… - Future medicinal …, 2009 - Taylor & Francis
Cannabinoids are a group of compounds that mediate their effects through cannabinoid
receptors. The discovery of Δ9-tetrahydrocannabinol (THC) as the major psychoactive …
receptors. The discovery of Δ9-tetrahydrocannabinol (THC) as the major psychoactive …
Cannabinoids, inflammation, and fibrosis
RB Zurier, SH Burstein - The FASEB Journal, 2016 - Wiley Online Library
Cannabinoids apparently act on inflammation through mechanisms different fromthose of
agents such as nonsteroidal anti‐inflammatory drugs (NSAIDs). As a class, the …
agents such as nonsteroidal anti‐inflammatory drugs (NSAIDs). As a class, the …
Pharmacological and therapeutic secrets of plant and brain (endo) cannabinoids
LO Hanuš - Medicinal research reviews, 2009 - Wiley Online Library
Research on the chemistry and pharmacology of cannabinoids and endocannabinoids has
reached enormous proportions, with approximately 15,000 articles on Cannabis sativa L …
reached enormous proportions, with approximately 15,000 articles on Cannabis sativa L …
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS
W Kong, H Li, RF Tuma, D Ganea - Cellular immunology, 2014 - Elsevier
CB2, the cannabinoid receptor expressed primarily on hematopoietic cells and activated
microglia, mediates the immunoregulatory functions of cannabinoids. The involvement of …
microglia, mediates the immunoregulatory functions of cannabinoids. The involvement of …
Ajulemic acid: potential treatment for chronic inflammation
SH Burstein - Pharmacology Research & Perspectives, 2018 - Wiley Online Library
Abstract Ajulemic acid (AJA, CT‐3, IP‐751, JBT‐101, anabasum) is a first‐in‐class,
synthetic, orally active, cannabinoid‐derived drug that preferentially binds to the CB2 …
synthetic, orally active, cannabinoid‐derived drug that preferentially binds to the CB2 …
Medical cannabis: a forward vision for the clinician
MA Fitzcharles, E Eisenberg - European Journal of Pain, 2018 - Wiley Online Library
Medical cannabis has entered mainstream medicine and is here to stay. Propelled by public
advocacy, the media and mostly anecdote rather than sound scientific study, patients …
advocacy, the media and mostly anecdote rather than sound scientific study, patients …
Posttranscriptional mechanisms regulating the inflammatory response
G Stoecklin, P Anderson - Advances in immunology, 2006 - Elsevier
The inflammatory response is a complex physiologic process that requires the coordinate
induction of cytokines, chemokines, angiogenic factors, effector‐enzymes, and proteases …
induction of cytokines, chemokines, angiogenic factors, effector‐enzymes, and proteases …
[PDF][PDF] Cannabinoid receptors: a brief history and" what's hot
Introduction 3. The cannabinoids: A brief history 3.1. Cannabinoids and the discovery of
cannabinoid receptors 3.2. Endocannabinoids 3.2. 1 Anandamide 3.2. 2 2-arachidonoyl …
cannabinoid receptors 3.2. Endocannabinoids 3.2. 1 Anandamide 3.2. 2 2-arachidonoyl …
Cannabidiol-induced apoptosis in primary lymphocytes is associated with oxidative stress-dependent activation of caspase-8
We recently reported that cannabidiol (CBD) exhibited a generalized suppressive effect on T-
cell functional activities in splenocytes directly exposed to CBD in vitro or isolated from CBD …
cell functional activities in splenocytes directly exposed to CBD in vitro or isolated from CBD …
[HTML][HTML] Cannabinoid reduces inflammatory cytokines tumor necrosis factor alpha and type I interferons in dermatomyositis in vitro
ES Robinson, P Alves, MM Bashir, M Zeidi… - The Journal of …, 2017 - ncbi.nlm.nih.gov
Cannabis has been used in medicinal preparations for centuries to treat diseases such as
chronic pain, neuropathy, and epilepsy. Recent research has identified anti-inflammatory …
chronic pain, neuropathy, and epilepsy. Recent research has identified anti-inflammatory …